# DuPont de Nemours, Inc.: Form 10-Q for the period ended Mar 31, 2018

- Company: [DuPont de Nemours, Inc.](/companies/dd.md) (CIK 1666700)
- Form: 10-Q
- Filed: 2018-05-04
- Accepted by EDGAR: May 4, 2018, 09:50 ET
- Period: 2018-03-31
- Accession: 0001666700-18-000025
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1666700/000166670018000025/dowdupont1q18033118.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1666700/000166670018000025/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2018-01-01 to 2018-03-31 | $16.32bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months, 2018-01-01 to 2018-03-31 | $768.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-01-01 to 2018-03-31 | $1.71bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months, 2018-01-01 to 2018-03-31 | $389.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-01-01 to 2018-03-31 | $1.10bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-01-01 to 2018-03-31 | $0.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-01-01 to 2018-03-31 | $0.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-01-01 to 2018-03-31 | 2,334,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2018-01-01 to 2018-03-31 | −$2.14bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2018-01-01 to 2018-03-31 | $776.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months, 2018-01-01 to 2018-03-31 | $880.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2018-01-01 to 2018-03-31 | $1.00bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-03-31 | $10.28bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-03-31 | $49.73bn | us-gaap:AssetsCurrent |
| Total assets | at 2018-03-31 | $192.44bn | us-gaap:Assets |
| Current liabilities | at 2018-03-31 | $26.62bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2018-03-31 | $32.05bn | us-gaap:LongTermDebt |
| Short-term borrowings | at 2018-03-31 | $2.41bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2018-03-31 | $101.26bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 91,648 characters.

On December 11, 2015, The Dow Chemical Company ("Dow") and E. I. du Pont de Nemours and Company ("DuPont") entered into an Agreement and Plan of Merger ("Merger Agreement"), as amended on March 31, 2017, to effect an all-stock merger of equals strategic combination resulting in a newly formed corporation named DowDuPont Inc. ("DowDuPont" or the "Company"). On August 31, 2017, pursuant to the Merger Agreement, Dow and DuPont each merged with wholly owned subsidiaries of DowDuPont ("Mergers") and, as a result of the Mergers, Dow and DuPont became subsidiaries of DowDuPont (collectively, the "Merger"). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement. Dow was determined to be the accounting acquirer in the Merger. As a result, the historical financial statements of Dow for the periods prior to the Merger are considered to be the historical financial statements of DowDuPont. The results of DuPont are included in DowDuPont's consolidated results from the Merger date forward.

DowDuPont intends to pursue, subject to the receipt of approval by the Board of Directors ("Board") of DowDuPont and customary closing conditions, the separation of the combined Company's agriculture, materials science and specialty products businesses through one or more tax-efficient transactions ("Intended Business Separations").

Except as otherwise indicated by the context, the term "Dow" includes Dow and its consolidated subsidiaries, "DuPont" includes DuPont and its consolidated subsidiaries, "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of Dow, and "Dow Silicones" means Dow Silicones Corporation (formerly known as Dow Corning Corporation, which changed its name effective as of February 1, 2018), a wholly owned subsidiary of Dow.

### Items Affecting Comparability of Financial Results

Due to the size of Dow and DuPont's businesses prior to the Merger, in this section certain supplemental unaudited pro forma financial information is provided that assumes the Merger had been consummated on January 1, 2016. Adjustments have been made in the unaudited pro forma financial information for (1) the preliminary purchase accounting impact, (2) accounting policy alignment, (3) the elimination of the effect of events that are directly attributable to the Merger Agreement (e.g., one-time transaction costs), (4) the elimination of the impact of transactions between Dow and DuPont, and (5) the elimination of the effect of consummated divestitures required as a condition of regulatory approval for the Merger. Events that are not expected to have a continuing impact on the combined results (e.g., inventory step-up costs) are excluded. These adjustments impacted the consolidated results as well as the reportable segments. For additional information, see the Supplemental Unaudited Pro Forma Combined Financial Information in this section.

### OVERVIEW

The following is a summary of the results from continuing operations for the three months ended March 31, 2018:

- The Company reported net sales in the first quarter of 2018 of $21.5 billion, up 63 percent from $13.2 billion in the first quarter of 2017. The Merger contributed 50 percent of the sales increase, impacting all segments except Industrial Intermediates & Infrastructure and Performance Materials & Coatings. The remainder of the increase reflected broad-based sales growth with increases across most segments and geographic regions.
- Volume increased 5 percent compared with the same period last year, as increases in Industrial Intermediates & Infrastructure (up 14 percent), Packaging & Specialty Plastics (up 9 percent), Nutrition & Biosciences (up 5 percent) and Electronics & Imaging (up 2 percent) more than offset declines in Agriculture (down 8 percent), Safety & Construction (down 3 percent), Performance Materials & Coatings (down 2 percent) and Transportation & Advanced Polymers (down 1 percent). Volume increased in all geographic regions, except U.S. & Canada which was flat, and led by a double-digit increase in Asia Pacific (up 16 percent).
- Local price was up 4 percent compared with the same period last year, driven primarily by broad-based pricing actions in response to higher feedstock and raw material costs. Local price increased in all geographic regions and all segments, except Packaging & Specialty Plastics which remained flat, including a double-digit increase in Industrial Intermediates & Infrastructure (up 11 percent).
- Currency had a favorable impact of 4 percent on sales, driven primarily by Europe, Middle East and Africa ("EMEA").
- Research and development ("R&D") expenses totaled $768 million in the first quarter of 2018, up from $419 million in the first quarter of 2017. Selling, general and administrative ("SG&A") expenses were $1,714 million in the first quarter of 2018, up from $759 million in the first quarter of 2017. R&D and SG&A expenses increased primarily due to the Merger.
- Restructuring and asset related charges (credits) - net was a $262 million charge in the first quarter of 2018, primarily consisting of $172 million of severance and related benefit costs, $48 million of asset write-downs and write-offs and $40 million of costs associated with exit and disposal activities.
- Integration and separation costs were $457 million in the first quarter of 2018, up from $109 million in the first quarter of 2017, primarily due to the Merger. Integration and separation costs include costs related to the Merger, post-Merger integration costs and Intended Business Separation activities and costs related to the ownership restructure of Dow Silicones.
- Sundry income (expense) - net was income of $115 million in the first quarter of 2018, up from expense of $444 million in the first quarter of 2017, which included a loss related to Dow's arbitration matter with Bayer CropScience.
- In the first quarter of 2018, the Company recorded a charge to the provision for income taxes of $71 million as a result of adjustments made from the enactment of the Tax Cuts and Jobs Act.
- On February 15, 2018, DowDuPont announced that its Board declared a first quarter dividend of $0.38 per share, which was paid on March 15, 2018, to shareholders of record on February 28, 2018.
- In the first quarter of 2018, the Company spent $1 billion on repurchases of DowDuPont common stock. Although there is no timeline to complete the share repurchase program, DowDuPont intends to repurchase approximately $1 billion of the Company's stock in the second quarter of 2018.

In addition to the financial highlights above, the following events occurred during or subsequent to the first quarter of 2018:

- On February 26, 2018, DowDuPont announced brand names for the three independent companies expected to be created under the Intended Business Separations. The Agriculture Division will assume the name CortevaTM Agriscience. The Materials Science Division will be called Dow and will retain the Dow diamond as its brand. The Specialty Products Division will be the new DuPont.
- On March 12, 2018, DowDuPont announced that Andrew N. Liveris will transition out of the role of Executive Chairman of DowDuPont, effective April 1, 2018, and Jeff Fettig, co-Lead Independent Director for DowDuPont, will serve as a non-employee Executive Chairman of the Board of DowDuPont. Liveris will continue as a director of DowDuPont through his previously announced retirement effective July 1, 2018.
- Dow started up two new production facilities on the U.S. Gulf Coast - a Low Density Polyethylene production facility and a NORDEL™ Metallocene ethylene propylene diene monomer ("EPDM") elastomers production facility, which leverage an advantaged feedstock position to support profitable growth of the Company's high value performance plastics franchise.
- On April 25, 2018, DowDuPont announced that its Board declared a dividend of $0.38 per share, payable June 15, 2018, to shareholders of record on May 31, 2018.

*In millions, except per share amounts*

| Selected Financial Data | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $21,510 | $13,230 |
| Cost of sales ("COS") | $16,315 | $10,194 |
| Percent of net sales | 75.8% | 77.1% |
| Research and development expenses | $768 | $419 |
| Percent of net sales | 3.6% | 3.2% |
| Selling, general and administrative expenses | $1,714 | $759 |
| Percent of net sales | 8.0% | 5.7% |
| Effective tax rate | 25.2% | 18.9% |
| Net income available for common stockholders | $1,104 | $888 |
| Earnings per common share – basic | $0.47 | $0.74 |
| Earnings per common share – diluted | $0.47 | $0.72 |

### RESULTS OF OPERATIONS

*In millions*

| Summary of Sales Results | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $21,510 | $13,230 |
| Pro forma net sales |  | $20,467 |

*Sales Variances by Segment and Geographic Region - As Reported*

| Percentage change from prior year | Three Months Ended Mar 31, 2018 Local Price & Product Mix | Currency | Volume | Portfolio & Other 1 | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Agriculture | 1% | 3% | (8)% | 147% | 143% |
| Performance Materials & Coatings | 9 | 4 | (2) | — | 11 |
| Industrial Intermediates & Infrastructure | 11 | 5 | 14 | — | 30 |
| Packaging & Specialty Plastics | — | 4 | 9 | 7 | 20 |
| Electronics & Imaging | 1 | 1 | 2 | 72 | 76 |
| Nutrition & Biosciences | 3 | 5 | 5 | 556 | 569 |
| Transportation & Advanced Polymers | 1 | 5 | (1) | 386 | 391 |
| Safety & Construction | 1 | 4 | (3) | 197 | 199 |
| Total | 4% | 4% | 5% | 50% | 63% |
| U.S. & Canada | 4% | —% | —% | 47% | 51% |
| EMEA | 4 | 11 | 5 | 55 | 75 |
| Asia Pacific | 4 | 3 | 16 | 54 | 77 |
| Latin America | 7 | — | 1 | 34 | 42 |
| Total | 4% | 4% | 5% | 50% | 63% |

1\. Portfolio & Other reflects sales related to the Merger (impacts all segments, except Performance Materials & Coatings and Industrial Intermediates & Infrastructure). Portfolio & Other also reflects the following divestitures: a portion of Dow AgroSciences' Brazil corn seed business ("DAS Divested Ag Business"), divested on November 30, 2017 (impacting Agriculture), global Ethylene Acrylic Acid copolymers and ionomers business ("EAA Business"), divested on September 1, 2017 (impacting Packaging & Specialty Plastics) and SKC Haas Display Films group of companies, divested June 30, 2017 (impacting Electronics & Imaging).

The Company reported net sales in the first quarter of 2018 of $21.5 billion, up 63 percent from $13.2 billion in the first quarter of 2017, primarily reflecting the Merger, increased selling prices and demand growth. Sales growth was broad-based with increases in all segments and geographic regions. Portfolio & Other changes contributed 50 percent of the sales increase and impacted all segments, except Performance Materials & Coatings and Industrial Intermediates & Infrastructure. Volume increased 5 percent compared with the same period last year, as increases in Industrial Intermediates & Infrastructure (up 14 percent), Packaging & Specialty Plastics (up 9 percent), Nutrition & Biosciences (up 5 percent) and Electronics & Imaging (up 2 percent) more than offset declines in Agriculture (down 8 percent), Safety & Construction (down 3 percent), Performance Materials & Coatings (down 2 percent) and Transportation & Advanced Polymers (down 1 percent). Volume increased in all geographic regions, except U.S. & Canada, which was flat, including a double-digit increase in Asia Pacific (up 16 percent). Local price was up 4 percent compared with the same period last year, with increases in all geographic regions, driven by pricing initiatives in response to higher feedstock and raw material costs. Local price increased in all segments, except Packaging & Specialty Plastics which was flat, with the most notable increases in Industrial Intermediates & Infrastructure (up 11 percent) and Performance Materials & Coatings (up 9 percent). Currency had a favorable impact of 4 percent on sales, driven primarily by EMEA (up 11 percent).

*Sales Variances by Segment and Geographic Region - Net Sales in Current Period Compared with Pro Forma Net Sales in Prior Period*

| Percentage change from prior year | Three Months Ended Mar 31, 2018 Local Price & Product Mix | Currency | Volume | Portfolio & Other 1 | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Agriculture | 1% | 2% | (28)% | —% | (25)% |
| Performance Materials & Coatings | 9 | 4 | (1) | — | 12 |
| Industrial Intermediates & Infrastructure | 11 | 5 | 14 | — | 30 |
| Packaging & Specialty Plastics | — | 4 | 8 | — | 12 |
| Electronics & Imaging | 1 | 2 | 1 | (5) | (1) |
| Nutrition & Biosciences | 1 | 4 | 4 | 12 | 21 |
| Transportation & Advanced Polymers | 5 | 6 | 3 | — | 14 |
| Safety & Construction | — | 4 | 3 | — | 7 |
| Total | 3% | 4% | (2)% | —% | 5% |
| U.S. & Canada | 2% | —% | (12)% | 1% | (9)% |
| EMEA | 4 | 11 | 3 | 1 | 19 |
| Asia Pacific | 3 | 3 | 12 | — | 18 |
| Latin America | 5 | — | (5) | 1 | 1 |
| Total | 3% | 4% | (2)% | —% | 5% |

1\. Pro forma net sales for Agriculture excludes sales related to the November 30, 2017, divestiture of the DAS Divested Ag Business for the period January 1, 2017 through March 31, 2017. Pro forma net sales for Packaging & Specialty Plastics excludes sales related to the September 1, 2017, divestiture of the EAA Business for the period January 1, 2017 through March 31, 2017. Portfolio & Other includes sales for the acquisition of FMC's Health and Nutrition Business (the "H&N Business") acquired on November 1, 2017, impacting Nutrition & Biosciences. Portfolio & Other also reflects the following divestitures: SKC Haas Display Films group of companies (divested June 30, 2017) and the authentication business (divested on January 6, 2017), both impacting Electronics & Imaging; and, the divestiture of the global food safety diagnostic business (divested February 28, 2017), impacting Nutrition & Biosciences.

The Company reported net sales in the first quarter of 2018 of $21.5 billion, up 5 percent from pro forma net sales of $20.5 billion in the first quarter of 2017, with increases across most segments and geographic regions. Double-digit net sales increases were reported in Industrial Intermediates & Infrastructure (up 30 percent), Nutrition & Biosciences (up 21 percent), Transportation & Advanced Polymers (up 14 percent) and Performance Materials & Coatings and Packaging & Specialty Plastics (both up 12 percent). These increases were partially offset by declines in Agriculture (down 25 percent) and Electronics & Imaging (down 1 percent). Net sales increased in EMEA (up 19 percent), Asia Pacific (up 18 percent) and Latin America (up 1 percent) and declined in U.S. & Canada (down 9 percent). Currency was up 4 percent compared with the same period last year, driven primarily by EMEA (up 11 percent). Local price was up 3 percent compared with the same period last year with increases in all geographic regions, driven by broad-based pricing actions as well as pricing initiatives in response to higher feedstock and raw material costs. Local price increased across most segments, including a double-digit increase in Industrial Intermediates & Infrastructure (up 11 percent). Local price in Packaging & Specialty Plastics and Safety & Construction were flat. Volume decreased 2 percent compared with the same period last year, as declines in Agriculture (down 28 percent) and Performance Materials & Coatings (down 1 percent) more than offset double-digit volume growth in Industrial Intermediates & Infrastructure (up 14 percent). Volume decreased in U.S. & Canada (down 12 percent) and Latin America (down 5 percent) and increased in Asia Pacific (up 12 percent) and EMEA (up 3 percent).

### Cost of Sales

COS was $16.3 billion in the first quarter of 2018, up from $10.2 billion in the first quarter of 2017. The increase was primarily due to the Merger, higher sales volume, higher feedstock and other raw material costs, increased planned maintenance turnaround costs and unplanned events. Cost of sales in the first quarter of 2018 was also negatively impacted by a $703 million charge for the fair value step-up in DuPont's inventories as a result of the Merger and the acquisition of the H&N Business, related to Agriculture ($639 million), Nutrition & Biosciences ($63 million) and Safety & Construction ($1 million).

### Research and Development Expenses

R&D expenses totaled $768 million in the first quarter of 2018, up from $419 million in the first quarter of 2017, primarily due to the Merger.

### Selling, General and Administrative Expenses

SG&A expenses were $1,714 million in the first quarter of 2018, up from $759 million in the first quarter of 2017, primarily due to the Merger.

### Amortization of Intangibles

Amortization of intangibles was $474 million in the first quarter of 2018, up from $155 million in the first quarter of 2017, primarily due to an increase in intangible assets as a result of the Merger. See Note 10 to the Consolidated Financial Statements for additional information on intangible assets.

### Restructuring and Asset Related Charges (Credits) - Net

#### DowDuPont Cost Synergy Program

In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted by the DowDuPont Board. The plan is designed to integrate and optimize the organization following the Merger and in preparation for the Intended Business Separations. Based on all actions approved to date under the Synergy Program, the Company expects to record total pretax restructuring charges of approximately $2 billion, comprised of approximately $845 million to $935 million of severance and related benefit costs; $400 million to $540 million of asset write-downs and write-offs, and $400 million to $450 million of costs associated with exit and disposal activities. The Synergy Program includes certain asset actions that are reflected in the preliminary fair value measurement of DuPont’s assets as of the merger date. Current estimated total pretax restructuring charges could be impacted by future adjustments to the preliminary fair value of DuPont’s assets.

In the first quarter of 2018, the Company recorded pretax restructuring charges of $260 million, consisting of severance and related benefit costs of $172 million, asset write-downs and write-offs of $48 million and costs associated with exit and disposal activities of $40 million. The restructuring charges by segment were as follows: $58 million in Agriculture, $11 million in Industrial Intermediates & Infrastructure, $3 million in Packaging & Specialty Plastics, $1 million in Electronics & Imaging, $7 million in Safety & Construction, $181 million in Corporate and a benefit of $1 million in Transportation & Advanced Polymers. The Company expects to record additional restructuring charges in 2018 and 2019 and expects the Synergy Program to be substantially completed by the end of 2019.

#### Dow 2016 Restructuring Plan

In the first quarter of 2018, Dow recorded a favorable adjustment to the 2016 restructuring charge related to costs associated with exit and disposal activities of $1 million (related to Performance Materials & Coatings). See Note 5 to the Consolidated Financial Statements for details on the Company's restructuring activities.

### Integration and Separation Costs

Integration and separation costs, which reflect costs related to the Merger, post-Merger integration and Intended Business Separation activities and costs related to the ownership restructure of Dow Silicones, were $457 million in the first quarter of 2018, up from $109 million in the first quarter of 2017. Integration and separation costs are related to the Corporate segment.

### Equity in Earnings of Nonconsolidated Affiliates

The Company's share of the earnings of nonconsolidated affiliates was $257 million in the first quarter of 2018, up from $196 million in the first quarter of 2017, primarily due to lower equity losses from Sadara Chemical Company ("Sadara") due to the continued ramp up of operations, and higher equity earnings from EQUATE Petrochemical Company K.S.C ("EQUATE") due to improved monoethylene glycol prices. These increases were partially offset by lower year-over-year equity earnings from the Thai joint ventures and the HSC Group, which reflected customer settlements in the first quarter of 2017 related to long-term polysilicon sales agreements.

### Sundry Income (Expense) - Net

Sundry income (expense) – net includes a variety of income and expense items such as the gain or loss on foreign currency exchange, interest income, dividends from investments, gains and losses on sales of investments and assets, non-operating pension and other postretirement benefit plan credits or costs, and certain litigation matters. Sundry income (expense) – net in the first quarter of 2018 was income of $115 million, compared with expense of $444 million in the first quarter of 2017. The first quarter of 2018 included income related to non-operating pension and other postretirement benefit plans, interest income, and a $20 million gain for post-closing adjustments on Dow's sale of its equity interest in MEGlobal (related to Industrial Intermediates & Infrastructure). These gains more than offset foreign currency exchange losses, which included a $50 million foreign exchange loss related to adjustments to foreign currency exchange contracts for the change in the U.S. tax rate (related to Corporate). The first quarter of 2017 included a $469 million loss related to Dow Agroscience's arbitration matter with Bayer CropScience (related to Agriculture). See Notes 1, 2, 6, 13 and 16 to the Consolidated Financial Statements for additional information.

### Interest Expense and Amortization of Debt Discount

Interest expense and amortization of debt discount was $350 million in the first quarter of 2018, up from $219 million in the first quarter of 2017. The increase was primarily related to debt assumed in the Merger.

### Provision for Income Taxes on Continuing Operations

The Company's effective tax rate fluctuates based on, among other factors, where income is earned, reinvestment assertions regarding foreign income and the level of income relative to tax credits available. The Company's tax rate is also influenced by the level of equity earnings, since most of the earnings from the Company's equity method investments are taxed at the joint venture level.

On December 22, 2017, the Tax Cuts and Jobs Act ("The Act") was enacted. The Act reduces the U.S. federal corporate income tax rate from 35 percent to 21 percent, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred, creates new provisions related to foreign sourced earnings, eliminates the domestic manufacturing deduction and moves towards a territorial system. The Company recorded additional adjustments related to The Act in the first quarter of 2018 which resulted in a charge of $71 million to "Provision for income taxes on continuing operations."

The effective tax rate for the first quarter of 2018 was 25.2 percent, compared with an effective tax rate of 18.9 percent for the first quarter of 2017. The tax rate in the first quarter of 2018 was favorably impacted by the reduced U.S. federal corporate tax rate and the tax benefits related to the issuance of stock-based compensation. The tax rate was unfavorably impacted by certain integration, separation and restructuring costs associated with the Intended Business Separations, as well as non-deductible amortization of the fair value step-up in DuPont’s inventories as a result of the Merger, along with certain provisions in The Act related to the taxability of foreign earnings.

The tax rate for the first three months of 2017 reflects a tax benefit from the Bayer CropScience arbitration matter and the adoption of Accounting Standards Update ("ASU") 2016-09, which resulted in the recognition of excess tax benefits related to stock-based compensation in the provision for income taxes. See Notes 7 and 13 to the Consolidated Financial Statements for additional information.

### Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $44 million in the first quarter of 2018, up from $27 million in the first quarter of 2017, primarily due to the Merger.

### Net Income Available for DowDuPont Inc. Common Stockholders

Net income available for common stockholders was $1,104 million, or $0.47 per share, in the first quarter of 2018, compared with $888 million, or $0.72 per share, in the first quarter of 2017. See Note 8 to the Consolidated Financial Statements for details on the Company's earnings per share calculations.

### SUPPLEMENTAL UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION

The following supplemental unaudited pro forma combined statement of income (the "unaudited pro forma income statement") for DowDuPont is presented to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, 2016. Activity for the three months ended March 31, 2017, was prepared on a pro forma basis (the “unaudited pro forma information”). The unaudited pro forma information was prepared in accordance with Article 11 of Regulation S-X. Pro forma adjustments have been made for (1) the preliminary purchase accounting impact, (2) accounting policy alignment, (3) the elimination of the effect of events that are directly attributable to the Merger Agreement (e.g., one-time transaction costs), (4) the elimination of the impact of transactions between Dow and DuPont, and (5) the elimination of the effect of consummated divestitures required as a condition of approval for the Merger. Events that are not expected to have a continuing impact on the combined results (e.g., inventory step-up costs) are excluded from the unaudited pro forma information. The unaudited pro forma information does not reflect restructuring or integration activities or other costs following the Merger that may be incurred to achieve cost or growth synergies of DowDuPont. The unaudited pro forma income statement provides shareholders with summary financial information and historical data that is on a basis consistent with how DowDuPont reports current financial information.

The Merger was accounted for under Accounting Standards Codification ("ASC") Topic 805, "Business Combinations" ("ASC 805"), under which Dow was designated as the accounting acquirer in the Merger for accounting purposes. Under ASC 805, Dow accounted for the transaction by using Dow historical financial information and accounting policies and adding the assets and liabilities of DuPont as of August 31, 2017 (the "Merger Date") at their respective fair values. The assets and liabilities of DuPont were measured based on various preliminary estimates at the Merger Date using assumptions that DowDuPont believes are reasonable based on information that was currently available. The fair value estimates reflected in the unaudited pro forma information are based on those used in the Current Report on Form 8-K/A filed with the SEC on October 26, 2017, and subsequent measurement period adjustments are not reflected. DowDuPont intends to complete and finalize the allocation of consideration as soon as practicable within the measurement period in accordance with ASC 805, but no later than one year following the closing date of the Merger. Differences between these preliminary estimates and the final acquisition accounting may occur and these differences could have a material impact on the accompanying unaudited pro forma income statement and DowDuPont’s future results of operations.

The unaudited pro forma income statement has been presented for informational purposes only and is not necessarily indicative of what DowDuPont’s results of operations actually would have been had the Merger been completed on January 1, 2016. In addition, the unaudited pro forma income statement does not purport to project the future operating results of the Company. The unaudited pro forma income statement was based on and should be read in conjunction with the separate historical financial statements and accompanying notes contained in each of the Dow and DuPont Quarterly Reports on Form 10-Q for the quarter ended March 31, 2017. See Notes 1 and 3 to the Consolidated Financial Statements for additional information.

*Unaudited Pro Forma Combined Statement of Income*

*Three Months Ended Mar 31, 2017*

*In millions, except per share amounts*

| Adjustments Historical Dow 1, 3 Historical DuPont 1, 3 | Reclass 2, 3 | Divestitures 4 | Pro Forma 5 | Pro Forma |
| --- | ---: | ---: | ---: | ---: |
| Net sales $13,230 $7,743 | $45 | $(484) | $(67) | $20,467 |
| Cost of sales 10,194 4,314 | 133 | (199) | (9) | 14,433 |
| Other operating charges — 204 | (204) | — | — | — |
| Research and development expenses 419 400 | (10) | (35) | 7 | 781 |
| Selling, general and administrative expenses 868 1,229 | (249) | (49) | 11 | 1,810 |
| Other (loss) income, net — 202 | (202) | — | — | — |
| Amortization of intangibles 155 — | 51 | — | 222 | 428 |
| Restructuring and asset related charges (credits) - net (1) 152 | — | — | — | 151 |
| Integration and separation costs — — | 279 | — | (37) | 242 |
| Equity in earnings of nonconsolidated affiliates 196 — | 18 | — | (6) | 208 |
| Sundry income (expense) - net (469) — | 124 | (2) | — | (347) |
| Interest income 25 — | (25) | — | — | — |
| Interest expense and amortization of debt discount 219 84 | — | — | (30) | 273 |
| Income from continuing operations before income taxes 1,128 1,562 | (40) | (203) | (237) | 2,210 |
| Provision for income taxes on continuing operations 213 224 | (40) | (32) | (84) | 281 |
| Income from continuing operations, net of tax 915 1,338 | — | (171) | (153) | 1,929 |
| Net income attributable to noncontrolling interests 27 8 | — | — | 2 | 37 |
| Net income from continuing operations attributable to DowDuPont Inc. 888 1,330 | — | (171) | (155) | 1,892 |
| Preferred stock dividends — 2 | — | — | (2) | — |
| Net income from continuing operations available for DowDuPont Inc. common stockholders $888 $1,328 | $— | $(171) | $(153) | $1,892 |
| Per common share data: |  |  |  |  |
| Earnings per common share from continuing operations - basic |  |  |  | $0.82 |
| Earnings per common share from continuing operations - diluted |  |  |  | $0.81 |
| Weighted-average common shares outstanding - basic |  |  |  | 2,315.7 |
| Weighted-average common shares outstanding - diluted |  |  |  | 2,341.2 |

1\. Reflects historical consolidated statements of income included in Dow's and DuPont's Quarterly Reports on Form 10-Q for the quarter ended March 31, 2017.

2\. Certain reclassifications were made to conform with the presentation used for DowDuPont. The reclassifications are consistent with those identified and disclosed in the Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

3\. Amounts have been updated to reflect certain reclassifications required under Accounting Standards Update 2017-07, "Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost," which was adopted on January 1, 2018, and required retrospective application.

4\. Includes the following divestitures agreed to with certain regulatory agencies as a condition of approval for the Merger: Dow’s EAA Business; the DAS Divested Ag Business; and DuPont’s cereal broadleaf herbicides and chewing insecticides portfolio as well as its crop protection research and development pipeline and organization. For additional information regarding these divestitures, see Note 4 to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

5\. Certain pro forma adjustments were made to illustrate the estimated effects of the Merger, assuming that the Merger had been consummated on January 1, 2016. The pro forma adjustments are consistent with those identified and disclosed in the Company's Current Report on Form 8-K/A filed with the SEC on October 26, 2017.

### OUTLOOK

The global economy continues to show solid momentum and broad-based growth, driven by consumer-led demand in both developed and developing economies. There are discrete headwinds, including continued volatility in the Company's input costs and weather-related softness in agriculture. However, leading indicators from manufacturing output, to improving energy markets, to employment and consumer spending remain largely positive, reflecting increased economic activity.

The DowDuPont portfolio benefits from these macro trends, and the Company sees its innovations and growth investments driving above-market growth. The Company sees this strength continuing into the second quarter.

Looking ahead, DowDuPont remains focused on its priorities: delivering the Company's operating and financial plan, including executing on growth projects and innovation launches; achieving synergy targets; and standing and spinning the intended companies on the stated timeline.

### SEGMENT RESULTS

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA (for the three months ended March 31, 2018) and pro forma Operating EBITDA (for the three months ended March 31, 2017) as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., “Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items. Pro forma Operating EBITDA is defined as pro forma earnings (i.e., pro forma “Income from continuing operations before income taxes") before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of adjusted significant items. Reconciliations of these measures can be found in Note 21 to the Consolidated Financial Statements. The Company also presents pro forma net sales for the three months ended March 31, 2017, as it is included in management’s measure of segment performance and is regularly reviewed by the CODM. Prior year data has been updated to conform with the current year presentation.

Pro forma adjustments used in the calculation of pro forma net sales and pro forma Operating EBITDA were determined in accordance with Article 11 of Regulation S-X and were based on the historical consolidated financial statements of Dow and DuPont, adjusted to give effect to the Merger as if it had been consummated on January 1, 2016. For additional information on the pro forma adjustments made, see Supplemental Unaudited Pro Forma Combined Financial Information in the preceding section.

### AGRICULTURE

The Agriculture segment leverages the Company’s technology, customer relationships and industry knowledge to improve the quantity, quality and safety of the global food supply and the global production agriculture industry. Land available for worldwide agricultural production is increasingly limited so production growth will need to be achieved principally through improving crop yields and productivity. The segment’s two global businesses, Seed and Crop Protection, deliver a broad portfolio of products and services that are specifically targeted to achieve gains in crop yields and productivity, including well-established brands of seed products, crop chemicals, seed treatment, agronomy and digital services. R&D focuses on leveraging germplasm and plant science technology to increase farmer productivity and to enhance the value of grains and oilseeds through improved seed traits, superior seed germplasm and effective use of crop protection solutions.

*In millions*

| Agriculture | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $3,808 | $1,568 |
| Pro forma net sales |  | $5,049 |
| Operating EBITDA | $891 |  |
| Pro forma Operating EBITDA |  | $1,461 |
| Equity earnings (losses) | $(1) | $2 |

| Agriculture Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2018 |
| --- | ---: |
| Local price & product mix | 1% |
| Currency | 3 |
| Volume | (8) |
| Portfolio & other | 147 |
| Total | 143% |
| Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to: |  |
| Local price & product mix | 1% |
| Currency | 2 |
| Volume | (28) |
| Portfolio & other | — |
| Total | (25)% |

Agriculture net sales were $3,808 million in the first quarter of 2018, up from $1,568 million in the first quarter of 2017. Agriculture net sales in the first quarter of 2018 were down 25 percent from pro forma net sales of $5,049 million in the first quarter of 2017. A 28 percent decline in volume was partially offset by improvements in currency and local price, of 2 percent and 1 percent, respectively.

The decline in volume was driven by weather-related delays to the start of the planting seasons in the Northern Hemisphere and Brazil, lower expected planted area in both U.S. & Canada and Brazil and lower sales in the Brazil safrinha season due to a shift to lower technology corn driven by the delayed summer season harvest. These volume declines were partially offset by improvements in sunflower seed sales in EMEA and growth in global insecticide sales.

The increase in local price was driven by continuing efforts to capture value in established brands across the Crop Protection portfolio globally.

Operating EBITDA was $891 million in the first quarter of 2018, down 39 percent from pro forma Operating EBITDA of $1,461 million in the first quarter of 2017. Volume declines driven by weather-related selling delays, lower expected planted area and an unfavorable mix driven by the shortened safrinha season were partially offset by cost synergies, favorable currency, higher selling price in Crop Protection and lower pension/OPEB costs.

### PERFORMANCE MATERIALS & COATINGS

The Performance Materials & Coatings segment consists of two global businesses - Coatings & Performance Monomers and Consumer Solutions. Using silicones, acrylics and cellulosics-based technology platforms, these businesses serve the needs of the coatings, home care, personal care, appliance and industrial end-markets. The segment has broad geographic reach with R&D and manufacturing facilities located in key geographic regions. This segment also includes the results of the HSC Group joint ventures.

*In millions*

| Performance Materials & Coatings | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $2,304 | $2,079 |
| Pro forma net sales |  | $2,063 |
| Operating EBITDA | $628 |  |
| Pro forma Operating EBITDA |  | $481 |
| Equity earnings | $41 | $91 |

| Performance Materials & Coatings Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2018 |
| --- | ---: |
| Local price & product mix | 9% |
| Currency | 4 |
| Volume | (2) |
| Portfolio & other | — |
| Total | 11% |
| Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to: |  |
| Local price & product mix | 9% |
| Currency | 4 |
| Volume | (1) |
| Portfolio & other | — |
| Total | 12% |

Performance Materials & Coatings net sales were $2,304 million in the first quarter of 2018, up from net sales of $2,079 million in the first quarter of 2017. Net sales increased 12 percent compared with pro forma net sales of $2,063 million in the first quarter of 2017, with local price up 9 percent, volume down 1 percent and a favorable impact from currency of 4 percent, primarily in EMEA. Local price increased in all geographic regions and in both businesses. Local price increased in Consumer Solutions primarily due to disciplined price/volume management in upstream silicone intermediates, as well as in performance silicone products. Coatings & Performance Monomers local price increased in all geographic regions in response to higher raw material costs. Volume decreased in Coatings & Performance Monomers due to weather-related supply constraints and proactive measures to shed low margin business. Consumer Solutions reported volume growth in upstream silicone intermediates and robust demand in personal and home care end-markets.

Operating EBITDA was $628 million in the first quarter of 2018, up 31 percent from pro forma Operating EBITDA of $481 million in the first quarter of 2017, as higher selling prices, improved product mix, the favorable impact of currency on sales and cost synergies more than offset increased feedstock and other raw material costs, the unfavorable impact of currency on costs and lower equity earnings from the HSC Group due to settlements with a customer related to a long-term polysilicon sales agreements in the first quarter of 2017.

### INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE

The Industrial Intermediates & Infrastructure segment consists of three global businesses: Construction Chemicals, Industrial Solutions, and Polyurethanes & CAV. These customer-centric global businesses develop and market customized materials using advanced technology and unique chemistries. These businesses serve the needs of market segments as diverse as appliance, coatings, infrastructure, and oil and gas. The segment has broad geographic reach and R&D and manufacturing facilities located in key geographic regions. This segment also includes a portion of the results of EQUATE, The Kuwait Olefins Company K.S.C. ("TKOC"), Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

Dow is responsible for marketing a majority of Sadara products outside of the Middle East zone through Dow's established sales channels. As part of this arrangement, Dow purchases and sells Sadara products for a marketing fee.

*In millions*

| Industrial Intermediates & Infrastructure | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $3,715 | $2,851 |
| Pro forma net sales |  | $2,847 |
| Operating EBITDA | $654 |  |
| Pro forma Operating EBITDA |  | $512 |
| Equity earnings | $149 | $73 |

| Industrial Intermediates & Infrastructure Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2018 |
| --- | ---: |
| Local price & product mix | 11% |
| Currency | 5 |
| Volume | 14 |
| Portfolio & other | — |
| Total | 30% |
| Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to: |  |
| Local price & product mix | 11% |
| Currency | 5 |
| Volume | 14 |
| Portfolio & other | — |
| Total | 30% |

Industrial Intermediates & Infrastructure net sales were $3,715 million in the first quarter of 2018, up from net sales of $2,851 million in the first quarter of 2017. Net sales increased 30 percent compared with pro forma net sales of $2,847 million in the same quarter last year, with volume up 14 percent, local price up 11 percent and currency up 5 percent. Polyurethanes & CAV volume increased in all geographic regions, except U.S. & Canada, with double-digit volume growth in EMEA and Asia Pacific. Volume growth was driven by new production from Sadara and increased demand for isocyanates as a result of tight industry supply/demand fundamentals, which was partially offset by lower volume in U.S. & Canada due to planned maintenance turnaround activity and outages from weather-related events. Industrial Solutions reported volume gains in all geographic regions driven by new production from Sadara and increased demand in products sold in electronics processing, crop protection and food and pharmaceutical applications, which more than offset the impact of planned maintenance turnaround activity and outages from weather-related events on the U.S. Gulf Coast. Construction Chemicals volume was flat as strong demand for acrylic-based products in U.S. & Canada was offset by lower volume from methyl cellulosics-based products in EMEA due to capacity constraints. Local price was up in all geographic regions and all businesses driven by higher raw material costs, pricing initiatives and tight market conditions due to planned and unplanned events in the industry. Currency had a favorable impact of 5 percent on sales, primarily in EMEA.

Operating EBITDA was $654 million in the first quarter of 2018, up 28 percent compared with pro forma Operating EBITDA of $512 million in the first quarter of 2017. Operating EBITDA increased as the impact of higher selling prices, demand growth, the favorable impact of currency on sales, cost synergies, higher equity earnings from the Kuwait joint ventures and lower equity losses from Sadara more than offset higher feedstock and other raw material costs, the unfavorable impact of currency on costs, weather-related outages on the U.S. Gulf Coast and higher maintenance turnaround spending.

### PACKAGING & SPECIALTY PLASTICS

The Packaging & Specialty Plastics segment is a market-oriented portfolio composed of two global businesses: Hydrocarbons & Energy and Packaging and Specialty Plastics. The segment is advantaged through its low cost position into key feedstocks and broad geographic reach, with manufacturing facilities located in all geographic regions. It also benefits from R&D expertise to deliver leading-edge technology that provides a competitive benefit to customers in food packaging and other high-growth end-use markets like transportation and consumer durables. Taken together, the businesses in this segment represent the world's leading plastics franchise. This segment also includes the results of The Kuwait Styrene Company K.S.C. and The SCG-Dow Group, as well as a portion of the results of EQUATE, TKOC, Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

Dow is responsible for marketing a majority of Sadara products outside of the Middle East zone through Dow’s established sales channels. As part of this arrangement, Dow purchases and sells Sadara products for a marketing fee.

*In millions*

| Packaging & Specialty Plastics | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $6,010 | $5,025 |
| Pro forma net sales |  | $5,382 |
| Operating EBITDA | $1,301 |  |
| Pro forma Operating EBITDA |  | $1,114 |
| Equity earnings | $59 | $33 |

| Packaging & Specialty Plastics Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2018 |
| --- | ---: |
| Local price & product mix | —% |
| Currency | 4 |
| Volume | 9 |
| Portfolio & other | 7 |
| Total | 20% |
| Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to: |  |
| Local price & product mix | —% |
| Currency | 4 |
| Volume | 8 |
| Portfolio & other | — |
| Total | 12% |

Packaging & Specialty Plastics net sales were $6,010 million in the first quarter of 2018, up from net sales of $5,025 million in the first quarter of 2017. Net sales increased 12 percent compared with pro forma net sales of $5,382 million in the same quarter last year, with volume up 8 percent, currency up 4 percent, primarily in EMEA, and flat local price. Volume increased in both businesses and across all geographic regions, supported by new capacity additions on the U.S. Gulf Coast and increased production at Sadara. Packaging and Specialty Plastics volume growth was driven by strong demand for food and specialty packaging and industrial and consumer packaging solutions, particularly in Asia Pacific and EMEA, as well as rigid packaging applications in all geographic regions. Volume also increased from strong demand growth in elastomers applications, with double-digit volume gains in photovoltaics in Asia Pacific and in hot melt adhesives in EMEA. Hydrocarbons & Energy volume increased due to higher sales of ethylene and ethylene by-products. Local price was flat as price increases in ethylene derivatives were offset by decreases in hydrocarbons prices.

Operating EBITDA was $1,301 million in the first quarter of 2018, up 17 percent from pro forma Operating EBITDA of $1,114 million in the first quarter of 2017. Compared with pro forma Operating EBITDA from the same quarter last year, Operating EBITDA increased as the impact of higher sales volume, increased supply from growth projects, cost synergies, currency, higher equity earnings and lower start-up and commissioning costs more than offset higher feedstock and other raw material costs and the impact of weather-related disruptions on the U.S. Gulf Coast.

### ELECTRONICS & IMAGING

The Electronics & Imaging segment is a leading global supplier of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The segment is a leading provider of materials and solutions for the fabrication of semiconductors and integrated circuits and also provides innovative metallization processes for metal finishing, decorative, and industrial applications. Electronics & Imaging is a leading global supplier of key materials for the manufacturing of photovoltaics ("PV") and solar cells, including innovative metallization pastes and back sheet materials for the production of solar cells and solar modules and in the advanced printing and packaging graphics industry providing flexographic printing inks, photopolymer plates, and platemaking systems used in digital printing applications for textile, commercial and home-office use. In addition, the segment provides cutting-edge materials for the manufacturing of rigid and flexible displays for liquid crystal displays ("LCD"), advanced-matrix organic light emitting diode ("AMOLED"), and quantum dot ("QD") applications.

*In millions*

| Electronics & Imaging | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $1,153 | $655 |
| Pro forma net sales |  | $1,164 |
| Operating EBITDA | $357 |  |
| Pro forma Operating EBITDA |  | $327 |
| Equity earnings | $7 | $— |

| Electronics & Imaging Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2018 |
| --- | ---: |
| Local price & product mix | 1% |
| Currency | 1 |
| Volume | 2 |
| Portfolio & other | 72 |
| Total | 76% |
| Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to: |  |
| Local price & product mix | 1% |
| Currency | 2 |
| Volume | 1 |
| Portfolio & other | (5) |
| Total | (1)% |

Electronics & Imaging net sales were $1,153 million in the first quarter of 2018, up from $655 million in the first quarter of 2017. Electronics & Imaging net sales in the first quarter of 2018 were down 1 percent from pro forma net sales of $1,164 million in the first quarter of 2017. Net sales declined as a 5 percent unfavorable impact from portfolio actions related to prior year divestitures of the SKC Haas Display Films and Authentication businesses, was partially offset by a 2 percent benefit from currency, volume growth of 1 percent and local price gains of 1 percent.

Volume growth in the segment was driven by gains in semiconductor and interconnect solutions, primarily in Asia Pacific. Increased semiconductor content in end-use applications drove strong demand in both memory and logic market segments. Continued demand for mobile phones and other consumer electronics, as well as industrial applications, drove volume gains in interconnect solutions. Partially offsetting this growth was a decline in photovoltaic & advanced materials on decreases in trichlorosilane ("TCS") due to supply constraints and decreases in TEDLAR® film and SOLAMET® paste as module production in China slowed in the quarter. Local price gains were driven by higher metals pricing.

Operating EBITDA was $357 million in the first quarter of 2018, up 9 percent from pro forma Operating EBITDA of $327 million in the first quarter of 2017. Lower pension/OPEB costs, cost synergies, volume growth and favorable currency, more than offset an unfavorable impact from portfolio actions and higher unit costs.

### NUTRITION & BIOSCIENCES

The Nutrition & Biosciences segment is an innovation-driven and customer-focused segment that provides solutions for the global food and beverage, pharma, personal care, energy and animal nutrition markets. The segment consists of two operating segments: Nutrition & Health and Industrial Biosciences. The Nutrition & Health business is one of the world's largest producers of specialty food ingredients, developing and manufacturing solutions for the global food and beverage market. The Nutrition & Health business is also one of the world's largest producers of cellulosic- and alginates-based pharma excipients. The Industrial Biosciences business is an industry pioneer and innovator that works with customers to improve the performance, productivity and sustainability of their products and processes through biotechnology and engineering solutions including enzymes, biomaterials, biocides and antimicrobial solutions and process technology.

*In millions*

| Nutrition & Biosciences | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $1,720 | $257 |
| Pro forma net sales |  | $1,424 |
| Operating EBITDA | $418 |  |
| Pro forma Operating EBITDA |  | $317 |
| Equity earnings | $3 | $4 |

| Nutrition & Biosciences Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2018 |
| --- | ---: |
| Local price & product mix | 3% |
| Currency | 5 |
| Volume | 5 |
| Portfolio & other | 556 |
| Total | 569% |
| Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to: |  |
| Local price & product mix | 1% |
| Currency | 4 |
| Volume | 4 |
| Portfolio & other | 12 |
| Total | 21% |

Nutrition & Biosciences net sales were $1,720 million in the first quarter of 2018, up from $257 million in the first quarter of 2017. Nutrition & Biosciences net sales in the first quarter of 2018 were up 21 percent from pro forma net sales of $1,424 million in the first quarter of 2017. The increase was due to a 12 percent net benefit from portfolio actions due to the acquisition of the H&N Business, a 4 percent benefit from currency, 4 percent in volume growth and a 1 percent increase in local price.

Volume growth in the segment was led by Nutrition & Health gains in probiotics and pharmaceuticals, coupled with increases in systems and texturants in Asia Pacific. Growth in probiotics was driven by increased demand in Asia Pacific and U.S. & Canada. Pharmaceuticals growth was led by increased demand for excipient applications in Asia Pacific and U.S. & Canada. Industrial Biosciences volume grew on improvement in clean technologies due to alkylation offerings in Asia Pacific and EMEA. Demand for microbial control solutions in energy markets and for bioactives in home and personal care applications also contributed to volume growth.

Operating EBITDA was $418 million in the first quarter of 2018, up 32 percent from pro forma Operating EBITDA of $317 million in the first quarter of 2017, driven by the favorable impact of portfolio actions, volume growth, cost synergies and lower pension/OPEB costs, partially offset by higher costs due to growth investments.

### TRANSPORTATION & ADVANCED POLYMERS

The Transportation & Advanced Polymers segment provides high-performance engineering resins, adhesives, lubricants and parts to engineers and designers in the transportation, electronics, medical, industrial and consumer end-markets to enable systems solutions for demanding applications and environments. The segment delivers a broad range of polymer-based high-performance materials in its product portfolio, including elastomers and thermoplastic and thermoset engineering polymers which are used by customers to fabricate components for mechanical, chemical and electrical systems. In addition, the segment produces innovative and differentiated adhesive technologies to meet customer specifications for durability, crash performance, and healthcare applications. Transportation & Advanced Polymers also targets the performance plastics and fluid solutions markets by developing technologies that differentiate customers’ products with improved performance characteristics.

*In millions*

| Transportation & Advanced Polymers | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $1,425 | $290 |
| Pro forma net sales |  | $1,251 |
| Operating EBITDA | $437 |  |
| Pro forma Operating EBITDA |  | $321 |
| Equity earnings | $3 | $— |

| Transportation & Advanced Polymers Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2018 |
| --- | ---: |
| Local price & product mix | 1% |
| Currency | 5 |
| Volume | (1) |
| Portfolio & other | 386 |
| Total | 391% |
| Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to: |  |
| Local price & product mix | 5% |
| Currency | 6 |
| Volume | 3 |
| Portfolio & other | — |
| Total | 14% |

Transportation & Advanced Polymers net sales were $1,425 million in the first quarter of 2018, up from $290 million in the first quarter of 2017. Transportation & Advanced Polymers net sales in the first quarter of 2018 were up 14 percent from pro forma net sales of $1,251 million in the first quarter of 2017. The increase was due to a 6 percent benefit from currency, a 5 percent increase in local price and 3 percent in volume growth.

The increase in local price, primarily in nylon enterprise & polyester, was driven by price gains in ZYTEL®, reflecting tight polymer supply and higher feedstock costs. Volume growth was primarily due to performance solutions led by growth in KALREZ® and VESPEL® in the electronics and aerospace markets, and performance resins due to DELRIN® and HYTREL® in the automotive market. Broad-based volume growth was driven by growth in both Asia Pacific and the U.S. and Canada.

Operating EBITDA was $437 million in the first quarter of 2018, up 36 percent from pro forma Operating EBITDA of $321 million in the first quarter of 2017, driven by lower pension/OPEB costs, favorable currency, sales gains and cost synergies, partially offset by higher raw material costs.

### SAFETY & CONSTRUCTION

The Safety & Construction segment is a leading provider of engineered products and integrated systems for a number of industries including construction, worker safety, energy, oil and gas, transportation, medical devices and water purification and separation. The segment satisfies the growing global needs of businesses, governments, and consumers for solutions that make life safer, healthier and better. By uniting market-driven science with the strength of highly regarded brands, the segment strives to bring new products and solutions to solve customers' needs faster, better and more cost effectively. The segment is a leader in safety consulting, selling training products as well as consulting services, to improve the safety, productivity and sustainability of organizations across a range of industries.

*In millions*

| Safety & Construction | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $1,299 | $434 |
| Pro forma net sales |  | $1,213 |
| Operating EBITDA | $354 |  |
| Pro forma Operating EBITDA |  | $292 |
| Equity earnings | $5 | $— |

| Safety & Construction Percentage change from prior year Change in Net Sales from Prior Period due to: | Three Months Ended Mar 31, 2018 |
| --- | ---: |
| Local price & product mix | 1% |
| Currency | 4 |
| Volume | (3) |
| Portfolio & other | 197 |
| Total | 199% |
| Change in Net Sales in Current Period from Pro Forma Net Sales in Prior Period due to: |  |
| Local price & product mix | —% |
| Currency | 4 |
| Volume | 3 |
| Portfolio & other | — |
| Total | 7% |

Safety & Construction net sales were $1,299 million in the first quarter of 2018, up from $434 million in the first quarter of 2017. Safety & Construction net sales in the first quarter of 2018 were up 7 percent from pro forma net sales of $1,213 million in the first quarter of 2017 due to a 4 percent benefit from currency and 3 percent in volume growth.

Volume growth was driven by gains in TYVEK® enterprise due to strength in protective materials from industrial personal protection, graphics and medical packaging, and in aramids, due to strength in NOMEX® thermal-resistant garments in composites and energy solutions. Volume gains in construction, due to CORIAN® Design, were partially offset by weakness in building solutions due to inclement weather in U.S. & Canada and Asia Pacific in Japan.

Operating EBITDA was $354 million in the first quarter of 2018, up 21 percent from pro forma Operating EBITDA of $292 million in the first quarter of 2017, due primarily to lower pension/OPEB costs, cost synergies, reliability improvements and favorable currency, partially offset by higher costs.

### CORPORATE

Corporate includes certain enterprise and governance activities (including insurance operations, environmental operations, geographic management, etc.); business incubation platforms; non-business aligned joint ventures; gains and losses on the sales of financial assets; severance costs; non-business aligned litigation expenses; discontinued or non-aligned businesses and pre-commercial activities.

*In millions*

| Corporate | Three Months Ended Mar 31, 2018 | Mar 31, 2017 |
| --- | ---: | ---: |
| Net sales | $76 | $71 |
| Pro forma net sales |  | $74 |
| Operating EBITDA | $(169) |  |
| Pro forma Operating EBITDA |  | $(211) |
| Equity losses | $(9) | $(7) |

Net sales for Corporate, which primarily relate to Dow's insurance operations, were $76 million in the first quarter of 2018, compared with net sales of $71 million in the first quarter of 2017 and pro forma net sales of $74 million in the first quarter of 2017.

Operating EBITDA was a loss of $169 million in the first quarter of 2018, compared with a pro forma Operating EBITDA loss of $211 million in the first quarter of 2017. Compared with pro forma Operating EBITDA from the same quarter last year, Operating EBITDA improved primarily due to lower discontinued business costs, lower pre-commercial expenses and cost synergies.

### SUPPLEMENTAL DIVISION INFORMATION

Discussion of segment revenue, operating EBITDA and price/volume metrics on a divisional basis for Agriculture is based on the results of the Agriculture segment; for Materials Science is based on the combined results of the Performance Materials & Coatings segment, the Industrial Intermediates & Infrastructure segment and the Packaging & Specialty Plastics segment; and for Specialty Products is based on the combined results of the Electronics & Imaging segment, the Nutrition and Biosciences segment, the Transportation & Advanced Polymers segment and the Safety & Construction segment. The Corporate segment is not included in the division metrics. The segment disclosures have been presented in this manner for informational purposes only and should not be viewed as an indication of each division’s current or future operating results on a standalone basis assuming completion of the Intended Business Separations. See the section entitled “Segment Results” for additional qualitative analysis on segment performance.

**Net Sales by Division** *Three Months Ended*

In millions *Mar 31, 2018 Mar 31, 2017 1*

Agriculture $ 3,808 $ 5,049

Performance Materials & Coatings 2,304 2,063

Industrial Intermediates & Infrastructure 3,715 2,847

Packaging & Specialty Plastics 6,010 5,382

Materials Science $ 12,029 $ 10,292

Electronics & Imaging 1,153 1,164

Nutrition & Biosciences 1,720 1,424

Transportation & Advanced Polymers 1,425 1,251

Safety & Construction 1,299 1,213

Specialty Products $ 5,597 $ 5,052

**Net Sales Variance by Division 1** *Three Months Ended Mar 31, 2018*

Percent change from prior year *Local Price & Product Mix Currency Volume Portfolio / Other 2 Total*

Agriculture 1 % 2 % (28 )% — % (25 )%

Materials Science 5 % 4 % 8 % — % 17 %

Specialty Products 2 % 4 % 3 % 2 % 11 %

**Operating EBITDA by Division** *Three Months Ended*

In millions *Mar 31, 2018 Mar 31, 2017 1*

Agriculture $ 891 $ 1,461

Performance Materials & Coatings 628 481

Industrial Intermediates & Infrastructure 654 512

Packaging & Specialty Plastics 1,301 1,114

Materials Science $ 2,583 $ 2,107

Electronics & Imaging 357 327

Nutrition & Biosciences 418 317

Transportation & Advanced Polymers 437 321

Safety & Construction 354 292

Specialty Products $ 1,566 $ 1,257

1\. Information for the three months ended March 31, 2017, was prepared on a pro forma basis.

2\. Pro forma net sales for Agriculture excludes sales related to the November 30, 2017, divestiture of a portion of the DAS Divested Ag Business for the period January 1, 2017 through March 31, 2017. Pro forma net sales for Materials Science excludes sales related to the September 1, 2017, divestiture of the EAA Business for the period January 1, 2017 through March 31, 2017. Portfolio & Other includes sales for the acquisition of the H&N Business acquired on November 1, 2017, impacting Specialty Products. Portfolio & Other also reflects the following divestitures: SKC Haas Display Films group of companies (divested June 30, 2017), the authentication business (divested on January 6, 2017), and the divestiture of the global food safety diagnostic business (divested February 28, 2017), all impacting Specialty Products.

### CHANGES IN FINANCIAL CONDITION

The Company had cash and cash equivalents and marketable securities of $10,538 million at March 31, 2018 and $14,394 million at December 31, 2017, of which $8,512 million at March 31, 2018 and $12,177 million at December 31, 2017, was held by subsidiaries in foreign countries, including United States territories. For each of its foreign subsidiaries, the Company makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

The Company is currently evaluating the impact of The Act on its permanent reinvestment assertion. In addition to the one-time transition tax, a deferred tax liability for withholding taxes was accrued on a portion of the unrepatriated earnings at December 31, 2017. At March 31, 2018, management believed that sufficient liquidity was available in the United States. In the event that additional foreign funds are needed in the United States, the Company has the ability to repatriate additional funds. The repatriation could result in an adjustment to the tax liability due to contributing factors such as withholding taxes and the impact of foreign currency movements. As such, it is not practicable to calculate the unrecognized deferred tax liability on undistributed foreign earnings.

The Company’s cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table. The results for the three months ended March 31, 2017 represent Dow only. The results for the three months ended March 31, 2018 reflect the results of both Dow and DuPont.

*In millions*

| Cash Flow Summary Cash provided by (used for): | Three Months Ended Mar 31, 2018 | Mar 31, 2017 1 |
| --- | ---: | ---: |
| Operating activities | $(2,137) | $(76) |
| Investing activities | 290 | (353) |
| Financing activities | (1,543) | (257) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 208 | 56 |
| Summary |  |  |
| Decrease in cash, cash equivalents and restricted cash | $(3,182) | $(630) |
| Cash, cash equivalents and restricted cash at beginning of period | 14,015 | 6,624 |
| Cash, cash equivalents and restricted cash at end of period | $10,833 | $5,994 |

1\. Updated for ASU 2016-15 and ASU 2016-18. See Notes 1 and 2 to the Consolidated Financial Statements for additional information.

#### Reclassification of Prior Period Amounts Related to Accounts Receivable Securitization

In connection with the review and implementation of ASU 2016-15, the Company changed the prior period presentation and amount of proceeds from interests in trade accounts receivable conduits due to additional interpretive guidance related to the required method for calculating the cash received from beneficial interests in the conduits. In the first three months of 2017, changes related to the calculation and presentation of proceeds from interests in trade accounts receivable conduits resulted in a total reclassification of $551 million in proceeds from cash used for operating activities to cash used for investing activities.

#### Cash Flows from Operating Activities

In the first three months of 2018, cash used for operating activities was $2,137 million, compared with cash used for operating activities of $76 million in the same period last year. For the first three months of 2018, cash used for working capital requirements, quarterly tax payments, pension contributions, and integration and separation costs more than offset increased cash earnings. For the first three months of 2017, cash used for working capital requirements and pension contributions more than offset cash earnings.

*In millions*

| Net Working Capital | Mar 31, 2018 | Dec 31, 2017 |
| --- | ---: | ---: |
| Current assets | $49,733 | $49,893 |
| Current liabilities | 26,617 | 26,128 |
| Net working capital | $23,116 | $23,765 |
| Current ratio | 1.87:1 | 1.91:1 |

#### Cash Flows from Investing Activities

In the first three months of 2018, cash provided by investing activities was $290 million, reflecting proceeds from sales and maturities of investments and proceeds from interests in trade accounts receivable conduits, which were partially offset by capital expenditures and purchases of investments. In the first three months of 2017, cash used for investing activities was $353 million, primarily due to capital expenditures and loans to Sadara, which were partially offset by proceeds from interests in trade accounts receivable conduits.

Capital spending was $776 million in the first three months of 2018, compared with $754 million in the first three months of 2017. The Company expects full year capital spending in 2018 to be approximately $4.2 billion to $4.4 billion. In addition, the Company expects approximately $600 million of additional capital spending for targeted cost synergy and business separation projects.

In the first three months of 2018, Dow entered into a shareholder loan reduction agreement with Sadara and converted $70 million of the existing loan balance into equity related to this agreement. Dow expects to loan between zero and $200 million to Sadara during the remainder of 2018. All or a portion of the outstanding loans to Sadara could potentially be converted into equity in future periods.

#### Cash Flows from Financing Activities

In the first three months of 2018, cash used for financing activities increased compared with the same period last year, primarily due to purchases of treasury stock, higher dividends paid to stockholders and lower proceeds from sales/issuances of common stock, which were partially offset by an increase in cash from the issuance of commercial paper and long-term debt.

### Free Cash Flow

The Company defines free cash flow as cash provided by operating activities less capital expenditures. Under this definition, free cash flow represents the cash that remains available to the Company, after investing in its asset base, to fund obligations using the Company's primary source of incremental liquidity - cash provided by operating activities. Free cash flow is an integral financial measure used in the Company's financial planning process. This financial measure is not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP financial measures of performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly, the Company's free cash flow definition may not be consistent with the methodologies used by other companies.

For additional information relating to the change in cash used for operating activities, see the discussion above under the section entitled "Cash Flows from Operating Activities."

*In millions*

| Reconciliation of "Cash Used for Operating Activities" to Free Cash Flow | Three Months Ended Mar 31, 2018 | Mar 31, 2017 1 |
| --- | ---: | ---: |
| Cash used for operating activities | $(2,137) | $(76) |
| Capital expenditures | (776) | (754) |
| Free Cash Flow | $(2,913) | $(830) |

1\. "Cash used for operating activities" was updated for ASU 2016-15 and ASU 2016-18. See Notes 1 and 2 to the Consolidated Financial Statements for additional information.

### Liquidity & Financial Flexibility

The Company’s primary source of incremental liquidity is cash provided by operating activities. The generation of cash from operations and each of Dow's and DuPont's (the "Subsidiaries") ability to access the commercial paper market, the long-term debt market, syndicated credit lines, bilateral credit lines and bank financing, including committed repurchase facilities, are expected to meet the Company’s cash requirements for working capital, capital expenditures, debt maturities, dividend payments, share repurchases, contributions to pension plans and other needs. The Company’s primary liquidity sources are through the Subsidiaries as discussed below. Management expects that the Company and each of the Subsidiaries will continue to have sufficient liquidity and financial flexibility to meet respective business obligations as they come due.

### Dow's Liquidity Sources

#### Credit Ratings

At April 30, 2018, Dow's credit ratings were as follows:

|  |  |  |  |
| --- | --- | --- | --- |
| **Credit Ratings** | Long-Term Rating | Short-Term Rating | Outlook |
| Standard & Poor’s | BBB | A-2 | Stable |
| Moody’s Investors Service | Baa2 | P-2 | Stable |
| Fitch Ratings | BBB | F2 | Rating Watch Positive |

74

Downgrades in Dow's credit ratings would increase borrowing costs on certain indentures and could impact its ability to access credit markets.

#### Commercial Paper - Dow

Dow issues promissory notes under U.S. and Euromarket commercial paper programs. At March 31, 2018, Dow had $500 million of commercial paper outstanding ($231 million at December 31, 2017). Dow maintains access to the commercial paper market at competitive rates. Amounts outstanding under Dow's commercial paper programs during the period may be greater, or less, than the amount reported at the end of the period. Subsequent to March 31, 2018, Dow issued approximately $550 million of commercial paper.

#### Committed Credit Facilities - Dow

In the event the Company has short-term liquidity needs, it can access liquidity through Dow's committed and available credit facilities. At March 31, 2018, Dow had total committed credit facilities of $10.9 billion with remaining available credit facilities of $6.4 billion. See Note 12 to the Consolidated Financial Statements for additional information on committed and available credit facilities.

In connection with the Dow Silicones ownership restructure, on May 31, 2016, Dow Silicones incurred $4.5 billion of indebtedness under a certain third party credit agreement ("Dow Term Loan Facility"). Dow subsequently guaranteed the obligations of Dow Silicones under the Dow Term Loan Facility and, as a result, the covenants and events of default applicable to the Dow Term Loan Facility are substantially similar to the covenants and events of default set forth in Dow's Five Year Competitive Advance and Revolving Credit Facility. In the second quarter of 2017, Dow Silicones exercised a 364-day extension option making amounts borrowed under the Dow Term Loan Facility repayable on May 29, 2018, and amended the Dow Term Loan Facility to include an additional 19-month extension option, at Dow Silicones' election, upon satisfaction of certain customary conditions precedent. On February 8, 2018, Dow Silicones delivered a notice of intent to exercise the 19-month extension option on the Dow Term Loan Facility.

#### Accounts Receivable Securitization Facilities - Dow

Dow has access to committed accounts receivable securitization facilities in the United States and Europe, from which amounts available for funding are based upon available and eligible accounts receivable within each of the facilities. Dow renewed the United States facility in June 2015 for a term that extends to June 2018. The Europe facility was renewed in July 2015 for a term that extends to July 2018.

In the fourth quarter of 2017, Dow suspended further sales of trade accounts receivable through these facilities and began reducing outstanding balances under these facilities through collections of trade accounts receivable previously sold to such conduits. Dow has the ability to resume such sales to the conduits, subject to certain prior notice requirements, at the discretion of Dow. See Note 11 to the Consolidated Financial Statements for additional information.

### DuPont's Liquidity Sources

#### Credit Ratings

At April 30, 2018, DuPont's credit ratings were as follows:

|  |  |  |  |
| --- | --- | --- | --- |
| **Credit Ratings** | Long-Term Rating | Short-Term Rating | Outlook |
| Standard & Poor’s | A- | A-2 | Stable |
| Moody’s Investors Service | A3 | P-2 | Negative |
| Fitch Ratings | A | F1 | Rating Watch Negative |

Downgrades in DuPont's credit ratings would increase borrowing costs on certain indentures and could impact its ability to access debt capital markets.

#### Commercial Paper - DuPont

DuPont issues promissory notes under U.S. commercial paper programs. At March 31, 2018, DuPont had $1,301 million of commercial paper outstanding. DuPont maintains access to the commercial paper market at competitive rates.

#### Committed Credit Facilities - DuPont

In the event the Company has short-term liquidity needs, it can access liquidity through DuPont's committed and available credit facilities. At March 31, 2018, DuPont had total committed credit facilities of $8.8 billion with remaining available credit facilities of $7.2 billion. See Note 12 to the Consolidated Financial Statements for additional information on committed and available credit facilities.

#### Term Loan and Revolving Credit Facilities - DuPont

In March 2016, DuPont entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as may be amended, from time to time, the "Term Loan Facility") under which DuPont may make up to seven term loan borrowings and amounts repaid or prepaid are not available for subsequent borrowings. The proceeds from the borrowings under the Term Loan Facility will be used for DuPont's general corporate purposes including debt repayment, working capital and funding a portion of the Company's costs and expenses. The Term Loan Facility was amended in 2018 to extend the maturity date to June 2020, at which time all outstanding borrowings, including accrued but unpaid interest, become immediately due and payable, and to extend the date on which the commitment to lend terminates to June 2019. At March 31, 2018, DuPont had made three term loan borrowings in an aggregate principal amount of $1.5 billion and had unused commitments of $3 billion under the Term Loan Facility. In addition, in 2018 DuPont amended its $3 billion revolving credit facility to extend the maturity date to June 2020.

#### Committed Receivable Repurchase Facility - DuPont

In February 2018, in line with seasonal agricultural working capital requirements, DuPont entered into a committed receivable repurchase agreement of up to $1.3 billion (the "2018 Repurchase Facility") which expires in December 2018. From time to time, DuPont and the banks modify the monthly commitment amounts to better align with working capital requirements. Under the 2018 Repurchase Facility, DuPont may sell a portfolio of available and eligible outstanding customer notes receivables within the Agriculture segment to participating institutions and simultaneously agree to repurchase at a future date. See Note 12 to the Consolidated Financial Statements for additional information.

### Debt

The Company’s public debt instruments and primary, private credit agreements (collectively "Debt Instruments") reside with the Subsidiaries. See Note 12 to the Consolidated Financial Statements for information related to the Subsidiaries' notes payable and long-term debt activity, including debt retired and issued. The following table reflects the debt of the Subsidiaries:

*In millions*

| Total Debt | Mar 31, 2018 Dow | DuPont | Total | Dec 31, 2017 Dow | DuPont | Total |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Notes payable | $792 | $1,619 | $2,411 | $484 | $1,464 | $1,948 |
| Long-term debt due within one year | 920 | 1,787 | 2,707 | 752 | 1,315 | 2,067 |
| Long-term debt | 19,596 | 9,747 | 29,343 | 19,765 | 10,291 | 30,056 |
| Total debt | $21,308 | $13,153 | $34,461 | $21,001 | $13,070 | $34,071 |

The Debt Instruments of the Subsidiaries contain, among other provisions, certain customary restrictive covenant and default provisions. Dow’s Five Year Competitive Advance and Revolving Credit Facility contains a financial covenant that Dow must maintain its ratio of consolidated indebtedness to its consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility equals or exceeds $500 million. The ratio of Dow’s consolidated indebtedness to its consolidated capitalization was 0.42 to 1.00 at March 31, 2018. DuPont’s Term Loan Facility and revolving credit facility (the "RCF") contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for DuPont and its consolidated subsidiaries not exceed 0.6667 to 1.00. At March 31, 2018, management believes each of the Subsidiaries were in compliance with all of their respective covenants and default provisions. For additional information on the Subsidiaries' debt covenants and default provisions, see Note 15 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2017.

### Dividends

On February 15, 2018, DowDuPont announced that its Board declared a first quarter dividend of $0.38 per share, paid on March 15, 2018, to shareholders of record on February 28, 2018. On April 25, 2018, the Company announced that its Board declared a dividend of $0.38 per share, payable June 15, 2018, to shareholders of record on May 31, 2018.

### Share Repurchase Program

On November 2, 2017, the Company announced the Board authorized an initial $4 billion share repurchase program, which has no expiration date. In the first quarter of 2018, the Company spent $1 billion on repurchases of DowDuPont common stock under the program. At March 31, 2018, $2 billion of the share repurchase program authorization remained available for additional purchases. Although there is no timeline to complete the share repurchase program, DowDuPont intends to repurchase approximately $1 billion of the Company's stock in the second quarter of 2018.

For additional information related to the share repurchase program, see Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

### Restructuring

#### DowDuPont Cost Synergy Program

The activities related to the DowDuPont Cost Synergy Program ("Synergy Program") are expected to result in additional cash expenditures of approximately $1,050 million to $1,190 million, primarily by the end of 2019, consisting of severance and related benefit costs and costs associated with exit and disposal activities, including environmental remediation (see Note 5 to the Consolidated Financial Statements). The Synergy Program includes certain asset actions that are reflected in the preliminary fair value measurement of DuPont’s assets as of the Merger date. Current estimated total pretax restructuring charges could be impacted by future adjustments to the preliminary fair value of DuPont’s assets. The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities and restructuring plan implementation costs; these costs will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time.

#### Restructuring Plans Initiated Prior to Merger

The activities related to Dow's 2016 restructuring plan are expected to result in additional cash expenditures of approximately $50 million, primarily through June 30, 2018, consisting of severance and related benefit costs and costs associated with exit and disposal activities, including environmental remediation (see Note 5 to the Consolidated Financial Statements).

### Contractual Obligations

Information related to the Company’s contractual obligations, commercial commitments and expected cash requirements for interest can be found in the Company's 2017 Annual Report on Form 10-K, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources. Additional information related to these obligations can be found in Notes 15, 16 and 19 to the Consolidated Financial Statements in the Company’s 2017 Annual Report on Form 10-K. With the exception of the item noted below, there have been no material changes in the Company’s contractual obligations since December 31, 2017.

*In millions*

| Contractual Obligations | Payments Due In 2018 | 2019-2020 | 2021-2022 | 2023 and beyond | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Purchase obligations 1 | $4,013 | $5,708 | $4,483 | $7,338 | $21,542 |

1\. Includes take-or-pay and throughput obligations and outstanding purchase orders and other commitments greater than $1 million, obtained through a survey conducted by the Subsidiaries.

### Off-balance Sheet Arrangements

Off-balance sheet arrangements are obligations the Company has with nonconsolidated entities related to transactions, agreements or other contractual arrangements. The Company holds variable interests in joint ventures accounted for under the equity method of accounting. The Company is not the primary beneficiary of these joint ventures and therefore is not required to consolidate the entities (see Note 20 to the Consolidated Financial Statements). In addition, see Note 11 to the Consolidated Financial Statements for information regarding the transfer of financial assets.

Guarantees arise in the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Subsidiaries undertake an obligation to guarantee the performance of others if specific triggering events occur. The Subsidiaries had combined outstanding guarantees at March 31, 2018 of $5,964 million, compared with $5,960 million at December 31, 2017. Additional information related to the guarantees of the Subsidiaries can be found in the “Guarantees” section of Note 13 to the Consolidated Financial Statements.

### Fair Value Measurements

See Note 19 to the Consolidated Financial Statements for additional information concerning fair value measurements.

### OTHER MATTERS

### Recent Accounting Guidance

See Note 2 to the Consolidated Financial Statements for a summary of recent accounting guidance.

### Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 (“2017 10-K”) describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. DowDuPont’s accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s 2017 10-K. Since December 31, 2017, there have been no material changes in the Company’s accounting policies that are impacted by judgments, assumptions and estimates.

### Asbestos-Related Matters of Union Carbide Corporation

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem. In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

The table below provides information regarding asbestos-related claims pending against Union Carbide and Amchem based on criteria developed by Union Carbide and its external consultants.

| Asbestos-Related Claim Activity | 2018 | 2017 |
| --- | ---: | ---: |
| Claims unresolved at Jan 1 | 15,427 | 16,141 |
| Claims filed | 1,932 | 1,907 |
| Claims settled, dismissed or otherwise resolved | (3,026) | (1,566) |
| Claims unresolved at Mar 31 | 14,333 | 16,482 |
| Claimants with claims against both Union Carbide and Amchem | (5,148) | (5,779) |
| Individual claimants at Mar 31 | 9,185 | 10,703 |

Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. In fact, there are no personal injury cases in which only Union Carbide and/or Amchem are the sole named defendants. For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

For additional information, see Asbestos-Related Matters of Union Carbide Corporation in Note 13 to the Consolidated Financial Statements and Part II, Item 1. Legal Proceedings.

## Market risk

As filed, 316 characters.

See Note 18 to the Consolidated Financial Statements. See also Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk, of the Company's 2017 Annual Report on Form 10-K for information on the Company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

## Controls and procedures

As filed, 1,169 characters.

### Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company carried out an evaluation, under the supervision and with the participation of the Company’s Disclosure Committee and the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

### Changes in Internal Control Over Financial Reporting

There were no changes in the Company's internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

### DowDuPont Inc. PART II - OTHER INFORMATION

## Risk factors

As filed, 191 characters.

There have been no material changes in the Company's risk factors discussed in Part I, Item 1A, Risk Factors, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

Filed May 4, 2018.
Source: SEC EDGAR, the filing index for accession 0001666700-18-000025. Last ingested by Listed: Nov 10, 2026, 16:51 ET. No prices; not investment advice.
